Piccart M - Search Results

1

Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.

Stahel R, Bogaerts J, Ciardiello F, de Ruysscher D, Dubsky P, Ducreux M, Finn S, Laurent-Puig P, Peters S, Piccart M, Smit E, Sotiriou C, Tejpar S, Van Cutsem E, Tabernero J. Stahel R, et al. Among authors: piccart m. Cancer Treat Rev. 2015 Feb;41(2):129-35. doi: 10.1016/j.ctrv.2014.12.004. Epub 2014 Dec 16. Cancer Treat Rev. 2015. PMID: 25533737 Free article. Review.

2

Taxoid compounds in breast cancer: current status and future prospects.

Piccart MJ. Piccart MJ. Cancer Treat Res. 1995;78:185-207. doi: 10.1007/978-1-4615-2007-8_9. Cancer Treat Res. 1995. PMID: 8595143 Review. No abstract available.

3

Use of bisphosphonates in cancer patients.

Body JJ, Coleman RE, Piccart M. Body JJ, et al. Among authors: piccart m. Cancer Treat Rev. 1996 Jul;22(4):265-87. doi: 10.1016/s0305-7372(96)90020-1. Cancer Treat Rev. 1996. PMID: 9025784 Review. No abstract available.

4

Conclusions: future strategies in the treatment of breast cancer.

Piccart MJ, Hortobagyi GN. Piccart MJ, et al. Semin Oncol. 1997 Feb;24(1 Suppl 3):S34-40. Semin Oncol. 1997. PMID: 9071339 Review.

5

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

de Valeriola D, Awada A, Roy JA, Di Leo A, Biganzoli L, Piccart M. de Valeriola D, et al. Among authors: piccart m. Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003. Drugs. 1997. PMID: 9279502 Review.

6

New cytotoxic agents.

Piccart M. Piccart M. Cancer Treat Rev. 1997 Jul;23 Suppl 1:S59-67. doi: 10.1016/s0305-7372(97)90008-6. Cancer Treat Rev. 1997. PMID: 9377603 Review. No abstract available.

7

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

Di Leo A, Cardoso F, Durbecq V, Giuliani R, Mano M, Atalay G, Larsimont D, Sotiriou C, Biganzoli L, Piccart MJ. Di Leo A, et al. Among authors: piccart mj. Int J Clin Oncol. 2002 Aug;7(4):245-53. doi: 10.1007/s101470200036. Int J Clin Oncol. 2002. PMID: 12202978 Review.

8

Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer.

Cardoso F, Di Leo A, Piccart MJ. Cardoso F, et al. Cancer Treat Rev. 2002 Dec;28(6):275-90. doi: 10.1016/s0305-7372(02)00091-9. Cancer Treat Rev. 2002. PMID: 12470979 Review.

9

Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.

Atalay G, Cardoso F, Awada A, Piccart MJ. Atalay G, et al. Among authors: piccart mj. Ann Oncol. 2003 Sep;14(9):1346-63. doi: 10.1093/annonc/mdg365. Ann Oncol. 2003. PMID: 12954573 Free article. Review.

10

Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancer.

Cardoso F, Durbecq V, Larsimont D, Paesmans M, Leroy JY, Rouas G, Sotiriou C, Renard N, Richard V, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: piccart mj. Int J Oncol. 2004 Jan;24(1):201-9. Int J Oncol. 2004. PMID: 14654958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters